Benitec Biopharma Ltd (NASDAQ:BNTC)

2.33
Delayed Data
As of 3:29pm ET
 -0.07 / -2.92%
Today’s Change
1.85
Today|||52-Week Range
4.90
-21.20%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues255.7K179.7K251.1K292.9K
 
 
 
 
 
Cost of Goods Sold2.9M4.7M4.0M4.3M
 
 
 
 
 
Depreciation And Amortization80.8K211.0K163.7K150.3K
 
 
 
 
 
 
Operating ExpensesGross Income-2.7M-4.7M-3.9M-4.2M
 
 
 
 
 
General Expenses9.0M13.6M8.3M8.2M
 
 
 
 
 
Research And Development5.2M9.7M5.2M5.3M
 
 
 
 
 
Total Operating Expenses12.0M18.5M12.5M12.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-11.7M-18.3M-12.2M-12.3M
 
 
 
 
 
Extraordinary Charge-892.0K-2.2M0.00-31.8K
 
 
 
 
Other Expenses477.3K2.3M-205.9K33.3K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-11.5M-18.0M-12.2M-12.1M
 
 
 
 
 
Income Taxes-1.9M0.00-7.9M-3.1M
 
 
 
 
Net Income-9.6M-18.0M-4.3M-9.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS5.8M7.2M8.9M10.5M
 
 
 
 
 
Shares To Calculate EPS Diluted5.8M7.2M8.9M10.5M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.64-$2.51-$0.48-$0.86
 
 
 
 
 
EPS Diluted-$1.64-$2.51-$0.48-$0.86